Design Therapeutics Insider Trades
NASDAQ: DSGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Design Therapeutics insider activity
No Design Therapeutics insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows William Arsani (Director) selling 345,000 shares at $5.25 on Aug 13, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put DSGN's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
DSGN insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 13, 2025 | William ArsaniDirector | Sale | 217,627 | $1.14M | Form 4 |
| Aug 13, 2025 | William ArsaniDirector | Sale | 345,000 | $1.81M | Form 4 |
| Dec 18, 2024 | Prasad DeepaDirector | Sale | 3,806 | $23.86K | Form 4 |
| Aug 9, 2024 | William ArsaniDirector | Sale | 814,874 | $3.46M | Form 4 |
| Mar 25, 2024 | Berger Heather A.Director | Buy | 1,300 | $4.87K | Form 4 |
| Mar 25, 2024 | Schmid John P.Director | Buy | 17,809 | $66.61K | Form 4 |
| Mar 22, 2024 | Schmid John P.Director | Buy | 9,156 | $33.13K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4